FGF13 Regulates Myocardial Ischemia-Reperfusion Injury via PGRN Glycosylation

BACKGROUND: Macrophage polarization and complement activation play a pivotal role in the pathogenesis of myocardial ischemia-reperfusion (I/R) injury. FGF13 (fibroblast growth factor 13) is a critical regulator of cardiac homeostasis. However, the role and mechanism of FGF13 in myocardial I/R injury remain unclear. METHODS: FGF13 expression was detected in cardiomyocytes after hypoxia/reoxygenation and in hearts subjected to myocardial I/R. Cardiomyocyte-specific FGF13 knockout and adeno-associated virus serotype 9-mediated overexpression mice were generated. Transcriptomic and proteomic analyses identified key downstream mechanisms. Immunoprecipitation-mass spectrometry, co-immunoprecipitation, and glycoproteomics identified PGRN (progranulin) as an FGF13-interacting protein and mapped its glycosylation site. Mechanistic studies were performed using Transwell cocultures of neonatal mouse cardiomyocytes and bone marrow-derived macrophages, together with molecular and biochemical approaches. Virtual screening and molecular dynamics simulations identified a small-molecule FGF13 inhibitor. RESULTS: FGF13 was upregulated in cardiomyocytes after myocardial I/R. Cardiomyocyte-specific FGF13 knockout alleviated, whereas overexpression exacerbated, cardiac dysfunction and myocardial injury after I/R. Mechanistically, FGF13, through its asparagine 121 residue, competitively occupied the asparagine 263 glycosylation site of PGRN, sterically preventing STT3A (STT3 oligosaccharyltransferase complex catalytic subunit A)-mediated glycosylation of asparagine 263 and suppressing PGRN secretion. FGF13 depletion restored PGRN glycosylation and secretion, which activated macrophage TNFR2/PI3K/AKT (tumor necrosis factor receptor 2/phosphoinositide 3-kinase/protein kinase B) signaling in a paracrine manner, promoted M2 polarization while suppressing M1 polarization, and inhibited complement activation and inflammation. The small-molecule FGF13 inhibitor CWD8 (1-[2-amino-2-methylpropyl]-5,5-dimethylpiperidin-3-ol) also attenuated myocardial I/R injury. CONCLUSIONS: Our findings highlight the critical role of FGF13 in myocardial I/R injury and reveal a competitive mechanism by which FGF13 hinders STT3A-mediated PGRN glycosylation. We identify the PGRN glycosylation-PI3K/AKT axis as the key downstream pathway mediating FGF13-regulated macrophage polarization and complement activation, suggesting that small-molecule FGF13 inhibitors may represent a promising therapeutic strategy for myocardial I/R injury.

Authors

Institutions

Publication Details

Journal
Circulation Research
Published
2026-11-13
DOI
https://doi.org/10.1161/circresaha.126.329008
Primary Topic
Cardiac Ischemia and Reperfusion
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

FGF13 Regulates Myocardial Ischemia-Reperfusion Injury via PGRN Glycosylation

Bingyan Guo, Yiyi Zhang, Hongkun Xue, Chuan Wang et al.
Circulation Research
Cardiac Ischemia and Reperfusion
article

FGF13 Regulates Myocardial Ischemia-Reperfusion Injury via PGRN Glycosylation

Bingyan Guo, Yiyi Zhang, Hongkun Xue, Chuan Wang, Yiming Dong, Yingke Yan, Xiang Gao, Hongkun Xue, Zhiming Zhao, Jianhong Shi, Wenhui Yang, Hongshan Yin, 王一丹, Yongfang Zhang, Handong Wang, Kun Liu, Yibo Liu, Simeng Lv, Longfei Li, Yawei Liu
article en

Abstract

BACKGROUND: Macrophage polarization and complement activation play a pivotal role in the pathogenesis of myocardial ischemia-reperfusion (I/R) injury. FGF13 (fibroblast growth factor 13) is a critical regulator of cardiac homeostasis. However, the role and mechanism of FGF13 in myocardial I/R injury remain unclear. METHODS: FGF13 expression was detected in cardiomyocytes after hypoxia/reoxygenation and in hearts subjected to myocardial I/R. Cardiomyocyte-specific FGF13 knockout and adeno-associated virus serotype 9-mediated overexpression mice were generated. Transcriptomic and proteomic analyses identified key downstream mechanisms. Immunoprecipitation-mass spectrometry, co-immunoprecipitation, and glycoproteomics identified PGRN (progranulin) as an FGF13-interacting protein and mapped its glycosylation site. Mechanistic studies were performed using Transwell cocultures of neonatal mouse cardiomyocytes and bone marrow-derived macrophages, together with molecular and biochemical approaches. Virtual screening and molecular dynamics simulations identified a small-molecule FGF13 inhibitor. RESULTS: FGF13 was upregulated in cardiomyocytes after myocardial I/R. Cardiomyocyte-specific FGF13 knockout alleviated, whereas overexpression exacerbated, cardiac dysfunction and myocardial injury after I/R. Mechanistically, FGF13, through its asparagine 121 residue, competitively occupied the asparagine 263 glycosylation site of PGRN, sterically preventing STT3A (STT3 oligosaccharyltransferase complex catalytic subunit A)-mediated glycosylation of asparagine 263 and suppressing PGRN secretion. FGF13 depletion restored PGRN glycosylation and secretion, which activated macrophage TNFR2/PI3K/AKT (tumor necrosis factor receptor 2/phosphoinositide 3-kinase/protein kinase B) signaling in a paracrine manner, promoted M2 polarization while suppressing M1 polarization, and inhibited complement activation and inflammation. The small-molecule FGF13 inhibitor CWD8 (1-[2-amino-2-methylpropyl]-5,5-dimethylpiperidin-3-ol) also attenuated myocardial I/R injury. CONCLUSIONS: Our findings highlight the critical role of FGF13 in myocardial I/R injury and reveal a competitive mechanism by which FGF13 hinders STT3A-mediated PGRN glycosylation. We identify the PGRN glycosylation-PI3K/AKT axis as the key downstream pathway mediating FGF13-regulated macrophage polarization and complement activation, suggesting that small-molecule FGF13 inhibitors may represent a promising therapeutic strategy for myocardial I/R injury.

Circulation Research
Hebei Medical University (CN), Third Hospital of Hebei Medical University (CN), Second Hospital of Hebei Medical University (CN), Hebei University of Chinese Medicine (CN), Affiliated Hospital of Hebei University (CN), Hebei University (CN)
Good health and well-being
Cardiac Ischemia and Reperfusion
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon